[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

China Live Attenuated Vaccine Market Research Report 2017

March 2017 | 96 pages | ID: C09E310C11CEN
QYResearch

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Live Attenuated Vaccine

Revenue, means the sales value of Live Attenuated Vaccine

This report studies Live Attenuated Vaccine in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
  • Astellas Pharma Inc
  • CSL Limited
  • Emergent BioSolutions
  • GlaxoSmithKline
  • Johnson&Johnson
  • MedImmune
  • Merck
  • Pfizer
  • Sanofi Pasteur
Market Segment by Regions (provinces), covering
  • South China
  • East China
  • Southwest China
  • Northeast China
  • North China
  • Central China
  • Northwest China
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
Split by Application, this report focuses on consumption, market share and growth rate of Live Attenuated Vaccine in each application, can be divided into
  • Application 1
  • Application 2
China Live Attenuated Vaccine Market Research Report 2017

1 LIVE ATTENUATED VACCINE MARKET OVERVIEW

1.1 Product Overview and Scope of Live Attenuated Vaccine
1.2 Live Attenuated Vaccine Segment by Type
  1.2.1 China Production Market Share of Live Attenuated Vaccine Type in 2015
  1.2.2 Type I
  1.2.3 Type II
1.3 Applications of Live Attenuated Vaccine
  1.3.1 Live Attenuated Vaccine Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
1.4 China Market Size (Value) of Live Attenuated Vaccine (2012-2022)
1.5 China Live Attenuated Vaccine Status and Outlook
1.6 Government Policies

2 CHINA LIVE ATTENUATED VACCINE MARKET COMPETITION BY MANUFACTURERS

2.1 China Live Attenuated Vaccine Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Live Attenuated Vaccine Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Live Attenuated Vaccine Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Live Attenuated Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Live Attenuated Vaccine Market Competitive Situation and Trends
  2.5.1 Live Attenuated Vaccine Market Concentration Rate
  2.5.2 Live Attenuated Vaccine Market Share of Top 3 and Top 5 Manufacturers

3 CHINA LIVE ATTENUATED VACCINE MANUFACTURERS PROFILES/ANALYSIS

3.1 Astellas Pharma Inc
  3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.1.2 Live Attenuated Vaccine Product Type, Application and Specification
    3.1.2.1 Product A
    3.1.2.2 Product B
  3.1.3 Astellas Pharma Inc Live Attenuated Vaccine Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.1.4 Main Business/Business Overview
3.2 CSL Limited
  3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.2.2 Live Attenuated Vaccine Product Type, Application and Specification
    3.2.2.1 Product A
    3.2.2.2 Product B
  3.2.3 CSL Limited Live Attenuated Vaccine Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.2.4 Main Business/Business Overview
3.3 Emergent BioSolutions
  3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.3.2 Live Attenuated Vaccine Product Type, Application and Specification
    3.3.2.1 Product A
    3.3.2.2 Product B
  3.3.3 Emergent BioSolutions Live Attenuated Vaccine Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.3.4 Main Business/Business Overview
3.4 GlaxoSmithKline
  3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.4.2 Live Attenuated Vaccine Product Type, Application and Specification
    3.4.2.1 Product A
    3.4.2.2 Product B
  3.4.3 GlaxoSmithKline Live Attenuated Vaccine Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.4.4 Main Business/Business Overview
3.5 Johnson&Johnson
  3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.5.2 Live Attenuated Vaccine Product Type, Application and Specification
    3.5.2.1 Product A
    3.5.2.2 Product B
  3.5.3 Johnson&Johnson Live Attenuated Vaccine Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.5.4 Main Business/Business Overview
3.6 MedImmune
  3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.6.2 Live Attenuated Vaccine Product Type, Application and Specification
    3.6.2.1 Product A
    3.6.2.2 Product B
  3.6.3 MedImmune Live Attenuated Vaccine Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.6.4 Main Business/Business Overview
3.7 Merck
  3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.7.2 Live Attenuated Vaccine Product Type, Application and Specification
    3.7.2.1 Product A
    3.7.2.2 Product B
  3.7.3 Merck Live Attenuated Vaccine Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.7.4 Main Business/Business Overview
3.8 Pfizer
  3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.8.2 Live Attenuated Vaccine Product Type, Application and Specification
    3.8.2.1 Product A
    3.8.2.2 Product B
  3.8.3 Pfizer Live Attenuated Vaccine Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.8.4 Main Business/Business Overview
3.9 Sanofi Pasteur
  3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.9.2 Live Attenuated Vaccine Product Type, Application and Specification
    3.9.2.1 Product A
    3.9.2.2 Product B
  3.9.3 Sanofi Pasteur Live Attenuated Vaccine Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.9.4 Main Business/Business Overview

4 CHINA LIVE ATTENUATED VACCINE CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2012-2017)

4.1 China Live Attenuated Vaccine Capacity, Production and Growth (2012-2017)
4.2 China Live Attenuated Vaccine Revenue and Growth (2012-2017)
4.3 China Live Attenuated Vaccine Production, Consumption, Export and Import (2012-2017)

5 CHINA LIVE ATTENUATED VACCINE PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China Live Attenuated Vaccine Production and Market Share by Type (2012-2017)
5.2 China Live Attenuated Vaccine Revenue and Market Share by Type (2012-2017)
5.3 China Live Attenuated Vaccine Price by Type (2012-2017)
5.4 China Live Attenuated Vaccine Production Growth by Type (2012-2017)

6 CHINA LIVE ATTENUATED VACCINE MARKET ANALYSIS BY APPLICATION

6.1 China Live Attenuated Vaccine Consumption and Market Share by Application (2012-2017)
6.2 China Live Attenuated Vaccine Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Application
  6.3.2 Emerging Markets/Countries

7 CHINALIVE ATTENUATED VACCINE MARKET ANALYSIS BY REGIONS (PROVINCES)

7.1 China Live Attenuated Vaccine Production, Production Value and Price by Regions (Provinces)(2012-2017)
  7.1.1 China Live Attenuated Vaccine Production and Market Share by Regions (Provinces)(2012-2017)
  7.1.2 China Live Attenuated Vaccine Production Value and Market Share by Regions (Provinces)(2012-2017)
  7.1.3 China Live Attenuated Vaccine Sales Price by Regions (Provinces)(2012-2017)
7.2 China Live Attenuated Vaccine Consumption by Regions (Provinces)(2012-2017)
7.3 China Live Attenuated Vaccine Production, Consumption, Export and Import (2012-2017)

8 LIVE ATTENUATED VACCINE MANUFACTURING COST ANALYSIS

8.1 Live Attenuated Vaccine Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Live Attenuated Vaccine

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Live Attenuated Vaccine Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Live Attenuated Vaccine Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 CHINA LIVE ATTENUATED VACCINE MARKET FORECAST (2017-2022)

12.1 China Live Attenuated Vaccine Capacity, Production, Revenue Forecast (2017-2022)
12.2 China Live Attenuated Vaccine Production, Import, Export and Consumption Forecast (2017-2022)
12.3 China Live Attenuated Vaccine Production Forecast by Type (2017-2022)
12.4 China Live Attenuated Vaccine Consumption Forecast by Application (2017-2022)
12.5 China Live Attenuated Vaccine Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
  12.5.1 China Live Attenuated Vaccine Production Forecast by Regions (Provinces)(2017-2022)
  12.5.2 China Live Attenuated Vaccine Consumption Forecast by Regions (Provinces)(2017-2022)
  12.5.3 China Live Attenuated Vaccine Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.6 Live Attenuated Vaccine Price Forecast (2017-2022)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Live Attenuated Vaccine
Figure China Production Market Share of Live Attenuated Vaccine by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Table Live Attenuated Vaccine Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure China Live Attenuated Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Table China Live Attenuated Vaccine Capacity of Key Manufacturers (2015 and 2016)
Table China Live Attenuated Vaccine Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Live Attenuated Vaccine Capacity of Key Manufacturers in 2015
Figure China Live Attenuated Vaccine Capacity of Key Manufacturers in 2016
Table China Live Attenuated Vaccine Production of Key Manufacturers (2015 and 2016)
Table China Live Attenuated Vaccine Production Share by Manufacturers (2015 and 2016)
Figure 2015 Live Attenuated Vaccine Production Share by Manufacturers
Figure 2016 Live Attenuated Vaccine Production Share by Manufacturers
Table China Live Attenuated Vaccine Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Live Attenuated Vaccine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Live Attenuated Vaccine Revenue Share by Manufacturers
Table 2016 China Live Attenuated Vaccine Revenue Share by Manufacturers
Table China Market Live Attenuated Vaccine Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Live Attenuated Vaccine Average Price of Key Manufacturers in 2015
Table Manufacturers Live Attenuated Vaccine Manufacturing Base Distribution and Sales Area
Table Manufacturers Live Attenuated Vaccine Product Type
Figure Live Attenuated Vaccine Market Share of Top 3 Manufacturers
Figure Live Attenuated Vaccine Market Share of Top 5 Manufacturers
Table Astellas Pharma Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astellas Pharma Inc Live Attenuated Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Astellas Pharma Inc Live Attenuated Vaccine Market Share (2012-2017)
Table CSL Limited Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CSL Limited Live Attenuated Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure CSL Limited Live Attenuated Vaccine Market Share (2012-2017)
Table Emergent BioSolutions Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Emergent BioSolutions Live Attenuated Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Emergent BioSolutions Live Attenuated Vaccine Market Share (2012-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Live Attenuated Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure GlaxoSmithKline Live Attenuated Vaccine Market Share (2012-2017)
Table Johnson&Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson&Johnson Live Attenuated Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Johnson&Johnson Live Attenuated Vaccine Market Share (2012-2017)
Table MedImmune Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table MedImmune Live Attenuated Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure MedImmune Live Attenuated Vaccine Market Share (2012-2017)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Live Attenuated Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Merck Live Attenuated Vaccine Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Live Attenuated Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Live Attenuated Vaccine Market Share (2012-2017)
Table Sanofi Pasteur Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Pasteur Live Attenuated Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi Pasteur Live Attenuated Vaccine Market Share (2012-2017)
Figure China Live Attenuated Vaccine Capacity, Production and Growth (2012-2017)
Figure China Live Attenuated Vaccine Revenue (Million USD) and Growth (2012-2017)
Table China Live Attenuated Vaccine Production, Consumption, Export and Import (2012-2017)
Table China Live Attenuated Vaccine Production by Type (2012-2017)
Table China Live Attenuated Vaccine Production Share by Type (2012-2017)
Figure Production Market Share of Live Attenuated Vaccine by Type (2012-2017)
Figure 2015 Production Market Share of Live Attenuated Vaccine by Type
Table China Live Attenuated Vaccine Revenue by Type (2012-2017)
Table China Live Attenuated Vaccine Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Live Attenuated Vaccine by Type (2012-2017)
Figure 2015 Revenue Market Share of Live Attenuated Vaccine by Type
Table China Live Attenuated Vaccine Price by Type (2012-2017)
Figure China Live Attenuated Vaccine Production Growth by Type (2012-2017)
Table China Live Attenuated Vaccine Consumption by Application (2012-2017)
Table China Live Attenuated Vaccine Consumption Market Share by Application (2012-2017)
Figure China Live Attenuated Vaccine Consumption Market Share by Application in 2015
Table China Live Attenuated Vaccine Consumption Growth Rate by Application (2012-2017)
Figure China Live Attenuated Vaccine Consumption Growth Rate by Application (2012-2017)
Table China Live Attenuated Vaccine Production by Regions (Provinces)(2012-2017)
Table China Live Attenuated Vaccine Production Market Share by Regions (Provinces)(2012-2017)
Table China Live Attenuated Vaccine Production Value by Regions (Provinces)(2012-2017)
Table China Live Attenuated Vaccine Production Value Market Share by Regions (Provinces)(2012-2017)
Table China Live Attenuated Vaccine Sales Price by Regions (Provinces)(2012-2017)
Table China Live Attenuated Vaccine Consumption by Regions (Provinces)(2012-2017)
Table China Live Attenuated Vaccine Consumption Market Share by Regions (Provinces)(2012-2017)
Table China Live Attenuated Vaccine Production, Consumption, Export and Import (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Live Attenuated Vaccine
Figure Manufacturing Process Analysis of Live Attenuated Vaccine
Figure Live Attenuated Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Live Attenuated Vaccine Major Manufacturers in 2015
Table Major Buyers of Live Attenuated Vaccine
Table Distributors/Traders List
Figure China Live Attenuated Vaccine Capacity, Production and Growth Rate Forecast (2017-2022)
Figure China Live Attenuated Vaccine Revenue and Growth Rate Forecast (2017-2022)
Table China Live Attenuated Vaccine Production, Import, Export and Consumption Forecast (2017-2022)
Table China Live Attenuated Vaccine Production Forecast by Type (2017-2022)
Table China Live Attenuated Vaccine Consumption Forecast by Application (2017-2022)
Table China Live Attenuated Vaccine Production Forecast by Regions (Provinces)(2017-2022)
Table China Live Attenuated Vaccine Consumption Forecast by Regions (Provinces)(2017-2022)
Table China Live Attenuated Vaccine Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)


More Publications